| 000 | 01758 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250511223248.0 | ||
| 264 | 0 | _c19901024 | |
| 008 | 199010s 0 0 eng d | ||
| 022 | _a0019-9567 | ||
| 024 | 7 |
_a10.1128/iai.58.10.3337-3347.1990 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKimura, A | |
| 245 | 0 | 0 |
_aPertussis toxin analog with reduced enzymatic and biological activities is a protective immunogen. _h[electronic resource] |
| 260 |
_bInfection and immunity _cOct 1990 |
||
| 300 |
_a3337-47 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAnaphylaxis _xetiology |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBacterial Vaccines _ximmunology |
| 650 | 0 | 4 |
_aBordetella Infections _xprevention & control |
| 650 | 0 | 4 |
_aBordetella pertussis _ximmunology |
| 650 | 0 | 4 | _aCells, Cultured |
| 650 | 0 | 4 | _aChi-Square Distribution |
| 650 | 0 | 4 | _aColony Count, Microbial |
| 650 | 0 | 4 | _aEnzyme-Linked Immunosorbent Assay |
| 650 | 0 | 4 | _aHemagglutination Tests |
| 650 | 0 | 4 |
_aHistamine _xadministration & dosage |
| 650 | 0 | 4 |
_aHypersensitivity, Immediate _xchemically induced |
| 650 | 0 | 4 | _aImmunization |
| 650 | 0 | 4 | _aImmunization, Passive |
| 650 | 0 | 4 | _aLeukocyte Count |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 | _aMice, Inbred BALB C |
| 650 | 0 | 4 | _aMitogens |
| 650 | 0 | 4 |
_aMixed Function Oxygenases _xmetabolism |
| 650 | 0 | 4 | _aNeutralization Tests |
| 650 | 0 | 4 |
_aPoly(ADP-ribose) Polymerases _xmetabolism |
| 650 | 0 | 4 |
_aToxoids _ximmunology |
| 700 | 1 | _aMountzouros, K T | |
| 700 | 1 | _aSchad, P A | |
| 700 | 1 | _aCieplak, W | |
| 700 | 1 | _aCowell, J L | |
| 773 | 0 |
_tInfection and immunity _gvol. 58 _gno. 10 _gp. 3337-47 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1128/iai.58.10.3337-3347.1990 _zAvailable from publisher's website |
| 999 |
_c2125493 _d2125493 |
||